Vaccine development is a complex and resource-intensive process. PPPs can facilitate the sharing of research and development costs, streamline regulatory approvals, and expedite the manufacturing and distribution of vaccines. This collaborative approach was instrumental during the COVID-19 pandemic, leading to the rapid development and deployment of effective vaccines.
